Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Genes and hormones cause hair loss, with four genes contributing equally.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Insulin resistance linked to obesity may increase COVID-19 severity.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Hair loss treatments work better with lifestyle changes.

Obese women with PCOS are more likely to have fatty liver disease.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.